NCCN 2023

NCCN 2023

Outcomes of Chemotherapy-Related Febrile Neutropenia Vary by Region

By

Leah Lawrence

Publish Date April 7, 2023

Research has revealed regional disparities in outcomes for patients who are hospitalized with chemotherapy-related febrile neutropenia in the United States.

NCCN 2023

Lack of Data to Support ICI Retreatment in Advanced Melanoma

By

Jessica Nye, PhD

Publish Date April 6, 2023

Immune checkpoint inhibitor retreatment in advanced melanoma is used in clinical practice, but there is a lack of evidence to support it, a study suggests.

NCCN 2023

NCCN Classification May Predict Long-Term Outcomes in Localized Prostate Cancer

By

Jessica Nye, PhD

Publish Date April 5, 2023

NCCN classification is associated with long-term outcomes in patients with localized prostate cancer, a new study suggests.

NCCN 2023

Esophageal Cancer Incidence on the Rise, Mortality on the Decline

By

Leah Lawrence

Publish Date April 5, 2023

The incidence of esophageal cancer increased significantly from 2005 to 2019, but the mortality rate decreased.

NCCN 2023

US Medical Oncologists Are Prescribing Fewer Opioids

By

Jessica Nye, PhD

Publish Date April 4, 2023

Medical oncologists in the United States have been writing fewer prescriptions for opioids since 2017, a new study suggests.

NCCN 2023

Ongoing Disruptions in Cancer Care Due to COVID-19

By

Jessica Nye, PhD

Publish Date April 3, 2023

Patients with cancer continued to experience COVID-19-related disruptions to their care in 2022, results of a survey suggest.